col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


45 Ergebisse       Seite 1

 [1] 
Wiley: International Journal of Cancer
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Mai―05 Timing of surgery and 1-year postoperative outcomes in patients with breast cancer and preoperative COVID-19 history: A matched, longitudinal, ambidirectional cohort study Yali Wang, Lijuan He, Minyan Chen, Lili Chen, Yuxiang Lin, Jialin Hou, et al. (+13)
2 [GO] 2025―Mrz―12 Safe prescribing in cancer patients during the COVID-19 pandemic and outcomes following restart of cancer care following SARS-CoV-2 infection: The COV-SPOT initiative Nathan Appanna, Rosie Mew, Sophie Williams, Thomas Starkey, Grisma Patel, Laura Hudson, et al. (+23)
3 [GO] 2024―Okt―03 Anxiety and depression in cancer patients and survivors in the context of restrictions in contact and oncological care during the COVID-19 pandemic Daniela Doege, Julien Frick, Rachel D. Eckford, Lena Koch-Gallenkamp, Michael Schlander, Volker Arndt
4 [GO] 2024―Sep―02 Humoral immune response as an indicator for protection against Covid-19 after anti-SARS-COV2-booster vaccination in hematological and oncological patients Dieter Mainka, Nathalie Bauer, Lutz Dietze, Sonja Lehnert, Johanna Krandick, Daniel Himmelreich, et al. (+5)
5 [GO] 2024―Jul―15 COVID-19 vaccinated children, adolescents, and young adults with acute lymphoblastic leukemia show spike reactive antibodies and multifunctional T-cells Rebecca S. Parker, Justin Le, Miguel Villa, Annie Luong, Tsen Yin Lin, Yesun Lee, et al. (+9)
6 [GO] 2024―Jun―05 Immune responses and reinfection of SARS-CoV-2 Omicron variant in patients with lung cancer Chen Chen, Xiaoyun Zhou, Xiaoxing Gao, Ruili Pan, Qi He, Xiaobei Guo, et al. (+6)
7 [GO] 2024―Mai―25 Effects of the Coronavirus disease 2019 pandemic on mortality in patients with lung cancer: A multiple mediation analysis in Japan Daisuke Miyamori, Tsukasa Kamitani, Shuhei Yoshida, Yuka Kikuchi, Yuya Shigenobu, Kotaro Ikeda, et al. (+2)
8 [GO] 2024―Mai―10 Cancer incidence, stage shift and survival during the 2020 COVID-19 pandemic: A population-based study in Belgium Hanna M. Peacock, Mira Van Meensel, Bart Van Gool, Geert Silversmit, Kris Dekoninck, James D. Brierley, Liesbet Van Eycken
9 [GO] 2024―Mai―09 Treatment of chronic COVID-19 with convalescent/postvaccination plasma in patients with hematologic malignancies Maike Janssen, Albrecht Leo, Cornelia Wolf, Miriam Stenzinger, Marie Bartenschlager, Juliane Brandt, et al. (+6)
10 [GO] 2024―Apr―29 Underdiagnosed cancer during COVID-19 pandemic and return to normality Antonio V. Sterpetti, Raimondo Gabriele, Immacolata Iannone, Valeria Borrelli
11 [GO] 2024―Apr―02 Indications of sustained delay of colorectal cancer diagnoses in Germany during the first 2 years of the COVID-19 pandemic Hermann Brenner, Lisa Weber, Rafael Cardoso, Thomas Heisser, Michael Hoffmeister, Bernd Holleczek
12 [GO] 2024―Apr―02 Clinical outcomes of coronavirus disease in patients with breast cancer treated with granulocyte colony-stimulating factor following chemotherapy: Triangulation of evidence using population-based cohort and Mendelian randomization analyses Yali Wang, Weifeng Cai, Peng He, Qindong Cai, Jinhua Huang, Shougui Liu, et al. (+12)
13 [GO] 2024―Feb―09 Changes in mortality associated with different hematologic malignancies during the pandemic in the United States Ugo Fedeli, Claudio Barbiellini Amidei, Xuesong Han, Ahmedin Jemal
14 [GO] 2024―Feb―08 Patient-reported outcomes in advanced NSCLC before and during the COVID-19 pandemic: Real-world data from the German prospective CRISP Registry (AIO-TRK-0315) Martin Sebastian, Wilfried E. E. Eberhardt, Eyck von der Heyde, Steffen Dörfel, Jörg Wiegand, Clemens Schiefer, et al. (+14)
15 [GO] 2024―Jan―25 Impact of COVID-19 on cancer incidence, presentation, diagnosis, treatment and survival in Northern Ireland Damien Bennett, Inez Murray, Helen Mitchell, Anna Gavin, David Donnelly
16 [GO] 2024―Jan―25 Continuity of care for patients with de novo metastatic cancer during the COVID-19 pandemic: A population-based observational study Ellis Slotman, Feike Weijzen, Heidi P. Fransen, Jolanda C. van Hoeve, Auke M. T. Huijben, Evelien J. M. Kuip, et al. (+8)
17 [GO] 2023―Dez―12 Risk of COVID-19 death for people with a pre-existing cancer diagnosis prior to COVID-19-vaccination: A systematic review and meta-analysis Julia Steinberg, Suzanne Hughes, Harriet Hui, Matthew J. Allsop, Sam Egger, Michael David, et al. (+56)
18 [GO] 2023―Nov―29 The United States experience with diagnosing and treating esophageal cancer during the SARS-CoV-2 pandemic: A retrospective cohort study Christina M. Stuart, Robert A. Meguid, Michael R. Bronsert, Salvador Rodriguez Franco, Benedetto Mungo, Richard D. Schulick, et al. (+4)
19 [GO] 2023―Nov―16 Changes in cancer incidence rates by stage during the COVID-19 pandemic in the US Elizabeth J. Schafer, Farhad Islami, Xuesong Han, Leticia M. Nogueira, Nikita Sandeep Wagle, K. Robin Yabroff, et al. (+2)
20 [GO] 2023―Nov―03 Impact of the COVID-19 pandemic on delivery of prostate cancer care in Australia: An interrupted time series analysis Brian Ng Hung Shin, Samuel Tan, Handoo Rhee, Eric Chung
21 [GO] 2023―Aug―04 No changes in clinical presentation, treatment strategies and survival of pancreatic cancer cases during the SARS-COV-2 outbreak: A retrospective multicenter cohort study on real-world data Emmanuelle Kempf, Sonia Priou, Guillaume Lamé, Alexis Laurent, Etienne Guével, Stylianos Tzedakis, et al. (+8)
22 [GO] 2023―Jun―01 Impact of the COVID-19 pandemic on the hospital attendance of patients with primary cervical cancer in Heilongjiang, China Lei Qi, Mingxing Wang, Yuehui Jia, Yuanyuan Wang, Liangfang Xue, Linlin Du, et al. (+12)
23 [GO] 2022―Dez―01 Safe prescribing in cancer patients during the COVID-19 pandemic: A new initiative from the UK Cancer Coronavirus Project (UKCCP) team Nathan Appanna, Grisma Patel, Emma Burke, Alexander Burnett, James Clark, Rosie Mew, et al. (+10)
24 [GO] 2022―Sep―09 Immunogenicity of two doses of inactive COVID-19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy Deniz Can Guven, Fatma Gul Gulbahce Incesu, Hasan Cagri Yildirim, Enes Erul, Elvin Chalabiyev, Burak Yasin Aktas, et al. (+9)
25 [GO] 2022―Sep―03 Immunogenicity of two doses of BNT162b2 and mRNA -1273 vaccines for solid cancer patients on treatment with or without a previous SARS-CoV -2 infection Nicla La Verde, Agostino Riva, Maria Silvia Cona, Arianna Gabrieli, Monica Cattaneo, Cinzia Fasola, et al. (+13)
26 [GO] 2022―Aug―27 Time intervals in the care pathway to cancer diagnosis during the Covid-19 pandemic: A large retrospective study from a high-volume center Xavier Bosch, Elisabet Montori-Palacin, Rosa Martínez-Ferrer, Anna Aldea, Pedro Moreno, Alfonso López-Soto
27 [GO] 2022―Jul―08 Susceptibility to SARS-Cov -2 Infection and Risk for Severe COVID -19 in Patients with Prostate Cancer on Androgen Deprivation Therapy Rolf Gedeborg, Stacy Loeb, Johan Styrke, Ritva Kiiski-Berggren, Hans Garmo, Pär Stattin
28 [GO] 2022―Jun―15 Covid-19 outbreak in Lombardy: impact on reducing solid cancer diagnoses in 2020 Annalisa Trama, Alice Bernasconi, Laura Botta, Serena Di Cosimo, Rosalba Miceli, Melanie Claps, et al. (+4)
29 [GO] 2022―Apr―14 The impact of the COVID -19 pandemic on cancer diagnosis based on pathology notifications: A comparison across the Nordic countries during 2020 Anna LV Johansson, Siri Larønningen, Charlotte Wessel Skovlund, Marnar Fríðheim Kristiansen, Lina Steinrud Mørch, Søren Friis, et al. (+12)
30 [GO] 2022―Mrz―07 The impact of the COVID -19 pandemic on the future incidence of acute lymphoblastic leukaemia in children: Projections for Germany under a COVID -19 related scenario Joachim Schüz, Arndt Borkhardt, Liacine Bouaoun, Friederike Erdmann
31 [GO] 2022―Jan―10 Impact of two waves of Sars-Cov2 outbreak on the number, clinical presentation, care trajectories and survival of patients newly referred for a colorectal cancer: A French multicentric cohort study from a large group of University hospitals Emmanuelle Kempf, Sonia Priou, Guillaume Lamé, Christel Daniel, Ali Bellamine, Daniele Sommacale, et al. (+11)
32 [GO] 2021―Dez―18 90-day mortality and clinical outcomes of patients with solid tumours and COVID -19 infection during the first pandemic outbreak in Catalonia, Spain: a multicentre retrospective study Jose Carlos Tapia, Javier Gavira, Assumpció López, Laia Llobera, Ona Pallise, Irene Marsal, et al. (+6)
33 [GO] 2021―Nov―29 Predicted long-term impact of COVID -19 pandemic-related care delays on cancer mortality in Canada Talía Malagón, Jean H.E. Yong, Parker Tope, Wilson H. Miller, Eduardo L. Franco, Wilson Miller, et al. (+61)
34 [GO] 2021―Okt―07 Mobility as a driver of SARS-CoV -2 in cancer patients during the second COVID -19 pandemic wave Dominic Fong, Maximilian J Mair, Florian Lanthaler, Monika Alber, Manfred Mitterer
35 [GO] 2021―Sep―04 Impact of the COVID -19 pandemic on population-based cancer registry Isabelle Soerjomataram, Aude Bardot, Joanne Aitken, Marion Piñeros, Ariana Znaor, Eva Steliarova-Foucher, et al. (+6)
36 [GO] 2021―Jun―21 Outcome of the randomized control screening trials on Oral, Cervix and Breast Cancer from India and way forward in COVID -19 pandemic situation Atul Budukh, Rajesh Dikshit, Pankaj Chaturvedi
37 [GO] 2021―Apr―29 Cancer care in East Africa amidst the Covid-19 pandemic Oliver Henke
38 [GO] 2021―Feb―26 The impact of the COVID -19 pandemic on the short-term survival of patients with cancer in Northern Portugal Samantha Morais, Luís Antunes, Jéssica Rodrigues, Filipa Fontes, Maria José Bento, Nuno Lunet
39 [GO] 2021―Feb―06 Cross-sectional survey of the impact of the COVID -19 pandemic on cancer screening programmes in selected low- and middle-income countries: study from the IARC COVID -19 impact study group Patricia Villain, Andre L Carvalho, Eric Lucas, Isabel Mosquera, Li Zhang, Richard Muwonge, et al. (+20)
40 [GO] 2021―Jan―11 Impact of the COVID -19 pandemic in cancer diagnosis in the first and second waves in one of the most affected cancer areas in the city of Madrid (Spain) Jacobo Rogado, Berta Obispo, Pedro Gullón, Miguel Ángel Lara
41 [GO] 2020―Dez―29 Why cancer control is fundamental during a pandemic Jean-Marc Bourque, Zuzanna Tittenbrun, Karin Hohman, Yannick Romero, Kalina Duncan, Lewis Foxhall, Sonali Johnson
42 [GO] 2020―Dez―07 Clinical features and outcomes of COVID-19 in Patients with Solid Tumors: Turkish National Registry Data Nuriye Özdemir, Ömer Dizdar, Ozan Yazıcı, Sercan Aksoy, Didem Sener Dede, Burçin Budakoğlu, et al. (+12)
43 [GO] 2020―Jun―23 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) infection in cancer population: Are patient-related symptoms helpful to track a harmful invisible? Sandra Assoun, Marc-Antoine Benderra, Jean-Pierre Lotz, Sandrine Richard, Joseph Gligorov
44 [GO] 2020―Jun―18 BREAST CANCER SCREENING OF MUTATION CARRIERS IN THE ERA OF COVID-19 PANDEMIC Angela Toss, Matteo Lambertini, Kevin Punie, Giovanni Grandi, Laura Cortesi
45 [GO] 2020―Jun―11 Low prevalence of IgG antibodies to SARS-CoV -2 in cancer patients with COVID -19 Tao Liu, Guang Zeng, Huangheng Tao, Yue Shi, Ting Wang, Tongzu Liu, et al. (+3)
 [1] 

45 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.006 sec